Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone mineral density comparison of mometasone, fluticasone, and montelukast in adults with asthma
2004-002930-21Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mometasone, fluticasone propionate and montelukast in asthma (4 arms), sponsored by Merck & Co. Primary endpoint: Mean percent change in lumbar spine bone mineral density. Started Jul 2006; status: completed.
02
Drugs
mometasonefluticasone propionatemontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-002930-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002930-21.